Not provided
Not provided
Not provided
Not provided
Not provided
No funding obtained.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment as Usual | No Intervention | Patients will receive the usual care from the treatment program | |
| iMET | Experimental | Participants will complete a self-guided computerized Motivational Enhancement Therapy |
|
| MET | Experimental | Clinician-delivered Motivational Enhancement Therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| iMET | Behavioral | Self-completed, computerized motivational enhancement therapy |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment engagement | We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Days abstinent | We will calculate the past-90-days number of days abstinent from any substance use and from the primary substance and the number of weeks abstinent from any substance use. | past-90-days |
| Driving/Riding Risk |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment process/quality | We will compare completion of the 2 MET sessions, and completion of the third follow-up visit between the iMET and MET conditions. | 60 days |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sion K Harris, PhD | Boston Children's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | United States |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D000437 | Alcoholism |
| D014029 | Tobacco Use Disorder |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D019973 | Alcohol-Related Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| C049391 | histaminol |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| MET |
| Behavioral |
Clinician-delivered Motivational Enhancement Therapy |
|
We will compare group trends in prevalence and frequency of past-90-days Driving while impaired or Riding with an impaired driver.
| past-90-days |
| HIV Risk Behavior | We will compare group trends in prevalence and frequency of past-90-days HIV Risk Behaviors. | past-90-days |